Pharmafile Logo

VJOncology

Takeda pilots Apple Watch depression app

Partners with Cognition Kit on patient monitoring wearable

- PMLiVE

NICE turns down first-line Keytruda for lung cancer

High cost of drug puts it above cost-effectiveness threshold

- PMLiVE

Stress testing for the perfect compliance storm

...as governments and regulators impose new legislation and strengthen their compliance regimes

Influence mapping to improve the efficiency and effectiveness of your messaging

As companies work to find innovative marketing techniques to cut through the noise, influence mapping has seen an increase in popularity. Associate Consultant Pany Koizi talks through how to get...

Blue Latitude Health

- PMLiVE

Amgen’s Kyprolis tops Velcade in myeloma trial

Hopes ENDEAVOR trial results will give it an edge over Takeda's brand

- PMLiVE

FDA sets August review date for Teva’s movement disorder drug

Could be first approved treatment for tardive dyskinesia

- PMLiVE

Artificial intelligence: could pharma lead the way?

Producing powerful, relevant user experiences will be one key area to target

- PMLiVE

Cuttsy+Cuttsy boosts health comms team

Charlotte Diggins joins while Jill Bradshaw and Dr Liz Walder take on new roles

- PMLiVE

Bayer: Post-truth politics severely handicaps innovation

And firm also voices its concerns over Brexit

MIT chief financial officer joins Moderna Therapeutics

Israel Ruiz to serve as audit committee chair on its board of directors

- PMLiVE

La Jolla plans filing on back of blood pressure trial data

Almost three-quarters of CRH patients met threshold for blood pressure response

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links